IMMUNOLOGICAL STUDY OF HUMAN RECOMBINANT INTERLEUKIN-2 (LOW-DOSE) IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA

被引：25
|
作者：
MARUMO, K [1 ]
MURAKI, J [1 ]
UENO, M [1 ]
TACHIBANA, M [1 ]
DEGUCHI, N [1 ]
BABA, S [1 ]
JITSUKAWA, S [1 ]
HATA, M [1 ]
TAZAKI, H [1 ]
机构：
[1] KEIO UNIV,SCH MED,DEPT UROL,TOKYO 108,JAPAN
来源：
UROLOGY | 1989年 / 33卷 / 03期
关键词：
D O I：
10.1016/0090-4295(89)90396-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：219 / 225
页数：7
相关论文
共 50 条
  • [21] Treatment Outcome of Low-dose Interleukin-2 Therapy in Patients with Metastatic Renal Cell Carcinoma
    Takezawa, Yuta
    Izumi, Kouji
    Shimura, Yusuke
    Aerken, Maolake
    Natsagdorji, Ariunbold
    Iijima, Masashi
    Shigehara, Kazuyoshi
    Nohara, Takahiro
    Narimoto, Kazutaka
    Kadono, Yoshifumi
    Kitagawa, Yasuhide
    Konaka, Hiroyuki
    Mizokami, Atsushi
    ANTICANCER RESEARCH, 2016, 36 (09) : 4961 - 4964
  • [22] Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma
    Negrier, S
    Escudier, B
    Lasset, C
    Douillard, JY
    Savary, J
    Chevreau, C
    Ravaud, A
    Mercatello, A
    Peny, J
    Mousseau, M
    Philip, T
    Tursz, T
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (18): : 1272 - 1278
  • [23] REGRESSION OF METASTATIC RENAL-CELL CARCINOMA FOLLOWING ADMINISTRATION OF PERIODATE-LYMPHOKINE ACTIVATED AUTOLOGOUS LEUKOCYTES AND LOW-DOSE RECOMBINANT INTERLEUKIN-2
    WANG, J
    WALLE, A
    GORDON, B
    NOVOGRODSKY, A
    SUTHANTHIRAN, M
    RUBIN, AL
    STENZEL, KH
    CLINICAL RESEARCH, 1987, 35 (03): : A529 - A529
  • [24] Effects of low-dose recombinant interleukin-2 in human malignancies
    Lissoni, P
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1997, 3 : S115 - S120
  • [25] RECOMBINANT INTERFERON-ALPHA-2A AND INTERLEUKIN-2 IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    JURINCICWINKLER, C
    HORLBECK, R
    KLIPPEL, KF
    WIENER KLINISCHE WOCHENSCHRIFT, 1993, 105 (10) : 271 - 276
  • [26] STUDIES OF THE IMMUNOLOGICAL EFFECTS OF INTERLEUKIN-2 IN PATIENTS WITH BLADDER-CANCER AND RENAL-CELL CARCINOMA
    HERMANN, GG
    APMIS, 1993, 101 : 3 - 26
  • [27] SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 IN A DOSE ESCALATING REGIMEN IN PATIENTS WITH METASTATIC RENAL-CELL ADENOCARCINOMA
    WHITEHEAD, RP
    WARD, D
    HEMINGWAY, L
    HEMSTREET, GP
    BRADLEY, E
    KONRAD, M
    CANCER RESEARCH, 1990, 50 (20) : 6708 - 6715
  • [28] METASTATIC RENAL-CELL CARCINOMA PATIENTS TREATED WITH INTERLEUKIN-2 OR INTERLEUKIN-2 PLUS INTERFERON-GAMMA - IMMUNOLOGICAL MONITORING
    FARACE, F
    PALLARDY, M
    ANGEVIN, E
    HERCEND, T
    ESCUDIER, B
    TRIEBEL, F
    INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (06) : 814 - 821
  • [29] INTERLEUKIN-2 AND INTERFERON IN RENAL-CELL CARCINOMA
    WERSALL, P
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1993, 10 (1-2): : 71 - 76
  • [30] METASTATIC RENAL-CELL CANCER TREATED WITH LOW-DOSE INTERLEUKIN-2 - A PHASE-II MULTICENTER STUDY
    STOTER, G
    FOSSA, SD
    RUGARLI, C
    SYMANN, M
    JASMIN, C
    ISRAEL, L
    BIJMAN, JT
    PALMER, P
    FRANKS, CR
    PHILIP, T
    CANCER TREATMENT REVIEWS, 1989, 16 : 111 - 113
12345